Insights into CD4+ memory T cells following Leishmania infection

Trends in Parasitology

Volumn 21, Issue 8, 2005, Pages 347-350

  Gollob, Kenneth J ^a   Antonelli, Lis R V ^a   Dutra, Walderez O ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; LEISHMANIA VACCINE; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; HOST; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; INFECTION CONTROL; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MEMORY CELL; NONHUMAN; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

LEISHMANIA MAJOR; MURINAE;

EID: 22044454588     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2005.06.007     Document Type: Short Survey

References (25)

1. A. Barral Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease Am. J. Trop. Med. Hyg. 44 1991 536 546
2. B.L. Herwaldt Leishmaniasis Lancet 354 1999 1191 1199
3. + T-cell subset differentiation Res. Immunol. 142 1991 36 40
4. + subset differentiation Infect. Agents Dis. 1 1992 33 42
5. C.R. Engwerda, and P.M. Kaye Organ-specific immune responses associated with infectious disease Immunol. Today 21 2000 73 78
6. J.M. Blackwell Genetic susceptibility to leishmanial infections: studies in mice and man Parasitology 112 Suppl. 1996 S67 S74
7. G.F. Spath Persistence without pathology in phosphoglycan-deficient Leishmania major Science 301 2003 1241 1243
8. C. Zaph Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites Nat. Med. 10 2004 1104 1110
9. S.M. Kaech Effector and memory T-cell differentiation: implications for vaccine development Nat. Rev. Immunol. 2 2002 251 262
10. O. Bacellar Up-regulation of Th1-type responses in mucosal leishmaniasis patients Infect. Immun. 70 2002 6734 6740
11. A.M. Da-Cruz T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy Clin. Diagn. Lab. Immunol. 9 2002 251 256
12. + regulatory T cells control Leishmania major persistence and immunity Nature 420 2002 502 507
13. P. Scott The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development Immunol. Rev. 201 2004 318 338
14. F. Sallusto Central memory and effector memory T cell subsets: function, generation, and maintenance Annu. Rev. Immunol. 22 2004 745 763
15. J.E. Uzonna Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease J. Immunol. 167 2001 6967 6974
16. C.R. Engwerda Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis Trends Parasitol. 20 2004 524 530
17. M.G. Mendonca Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J. Infect. Dis. 189 2004 1018 1023
18. A. Schubach Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure Am. J. Trop. Med. Hyg. 58 1998 824 827
19. P. Desjeux Global control and Leishmania HIV co-infection Clin. Dermatol. 17 1999 317 325
20. I. Follador Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection Clin. Infect. Dis. 34 2002 E54 E58
21. + effector and memory T cell generation Nat. Immunol. 4 2003 835 842
22. + T cells from the lymph node to the peripheral blood of early cutaneous leishmaniasis patients Immunol. Lett. 90 2003 155 159
23. R.L. Bottrel Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis Infect. Immun. 69 2001 3232 3239
24. L.R. Antonelli Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation Clin. Exp. Immunol. 136 2004 341 348
25. P.M. Kaye The immunopathology of experimental visceral leishmaniasis Immunol. Rev. 201 2004 239 253